🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting substances of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Elimination

According to TikTok, the service has removed violative material and prohibited associated hashtags and query recommendations. The organization stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with photos of weight loss, glowing reviews and detailed guides for preparing or administering at residence.

Within moments of joining one community, a vendor shared contact information, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Costs

Inside these groups, posts show black plastic parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram stated it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially significant medical dangers”.